26129-32-8

Basic information

• Product Name: Clofop
• Synonyms: Brn 1996227;Clofop [iso];Hoe 19453;Lf 479;Propanoic acid, 2-(4-(4-chlorophenoxy)phenoxy)-;2-[4-(4-chlorophenoxy)phenoxy]-;Clofop;LABOTEST-BB LT00239222
• CAS NO: 26129-32-8
• Molecular Formula: C₁₅H₁₃ClO₄
• Molecular Weight: 292.72
• EINECS: 255-626-9
• Product Categories: API intermediates
• Mol File: 26129-32-8.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 405.77°C (rough estimate)
• Flash Point: 215 °C
• Appearance: /
• Density: 1.2455 (rough estimate)
• Vapor Pressure: 3.17E-08mmHg at 25°C
• Refractive Index: 1.4429 (estimate)
• PKA: 3.22±0.10(Predicted)
• CAS DataBase Reference: Clofop(CAS DataBase Reference)
• NIST Chemistry Reference: Clofop(26129-32-8)
• EPA Substance Registry System: Clofop(26129-32-8)

Safety Data

• Hazardous Substances Data: 26129-32-8(Hazardous Substances Data)

Usage

General Description

Clofop is a chemical compound that belongs to the class of phenoxy herbicides, which are commonly used in agriculture to control broadleaf weeds. It acts by inhibiting the action of an enzyme called acetolactate synthase, which is crucial for the biosynthesis of branched-chain amino acids in plants. This disruption leads to the suppression of protein synthesis and ultimately the death of the target weeds. Clofop is known for its selective action against broadleaf weeds and has been widely used in various crops such as soybeans, corn, and wheat. However, its use has raised concerns about its potential environmental and health impacts, as well as the development of herbicide-resistant weeds. Therefore, the usage and application of clofop are closely regulated in many countries.

InChI:InChI=1/C15H13ClO4/c1-10(15(17)18)19-12-6-8-14(9-7-12)20-13-4-2-11(16)3-5-13/h2-10H,1H3,(H,17,18)

Upstream product

• 21567-18-0 4-(4-chlorophenoxy)phenol 
• 535-11-5 Ethyl 2-bromopropionate 
• 104-92-7 1-bromo-4-methoxy-benzene 
• 40843-46-7 4-(4-chlorophenoxy)anisole 
• 106-48-9 4-chloro-phenol 
• 51337-67-8 D-(+)-2-[4-(4-chlorophenoxy)-phenoxy]propionic acid ethyl ester 
• 49562-28-9 fenofibrate 

Downstream Products

• 51337-85-0 N-Butyl-2-[4-(4-chloro-phenoxy)-phenoxy]-N-methyl-propionamide 
• 51337-75-8 2-[4-(4-Chloro-phenoxy)-phenoxy]-thiopropionic acid S-propyl ester 
• 65633-47-8 2-[4'-(4-chlorophenoxy)phenoxy]-propionic acid 4-chlorobut-1-yl ester 
• 51337-90-7 2-[4-(4-Chloro-phenoxy)-phenoxy]-N-[3-(1,1,2,2-tetrafluoro-ethoxy)-phenyl]-propionamide 
• 64380-94-5 2-[4-(4-Chloro-phenoxy)-phenoxy]-propionic acid (2-chloro-phenoxycarbonylamino)-methyl ester 
• 64855-75-0 2-<4-(4-Chlorphenoxy)-phenoxy>-propionsaeureamid 
• 51337-89-4 2-[4-(4-Chloro-phenoxy)-phenoxy]-N-(3-trifluoromethyl-phenyl)-propionamide 
• 51337-87-2 2-[4-(4-Chloro-phenoxy)-phenoxy]-N-(4-chloro-phenyl)-propionamide 
• 66497-84-5 2-[4-(4-Chloro-phenoxy)-phenoxy]-propionic acid methoxycarbonylmethyl ester 
• 51337-81-6 2-[4-(4-Chloro-phenoxy)-phenoxy]-thiopropionic acid S-phenyl ester 
• 51337-83-8 2-[4-(4-Chloro-phenoxy)-phenoxy]-N,N-dimethyl-propionamide 
• 51337-84-9 2-[4-(4-Chloro-phenoxy)-phenoxy]-N,N-diethyl-propionamide 
• 51337-82-7 2-[4-(4-Chloro-phenoxy)-phenoxy]-thiopropionic acid S-(4-chloro-phenyl) ester 
• 51337-88-3 2-[4-(4-Chloro-phenoxy)-phenoxy]-N-(3,4-dichloro-phenyl)-propionamide 

Relevant articles and documents

Functional and Structural Insights into Human PPARα/δ/Subtype Selectivity of Bezafibrate, Fenofibric Acid, and Pemafibrate

Among the agonists against three peroxisome proliferator-activated receptor (PPAR) subtypes, those against PPARα (fibrates) and PPARγ (glitazones) are currently used to treat dyslipidemia and type 2 diabetes, respectively, whereas PPARδ agonists are expected to be the next-generation metabolic disease drug. In addition, some dual/pan PPAR agonists are currently being investigated via clinical trials as one of the first curative drugs against nonalcoholic fatty liver disease (NAFLD). Because PPARα/δ/γ share considerable amino acid identity and three-dimensional structures, especially in ligand-binding domains (LBDs), clinically approved fibrates, such as bezafibrate, fenofibric acid, and pemafibrate, could also act on PPARδ/γ when used as anti-NAFLD drugs. Therefore, this study examined their PPARα/δ/γ selectivity using three independent assays—a dual luciferase-based GAL4 transactivation assay for COS-7 cells, time-resolved fluorescence resonance energy transfer-based coactivator recruitment assay, and circular dichroism spectroscopy-based thermostability assay. Although the efficacy and efficiency highly varied between agonists, assay types, and PPAR subtypes, the three fibrates, except fenofibric acid that did not affect PPARδ-mediated transactivation and coactivator recruitment, activated all PPAR subtypes in those assays. Furthermore, we aimed to obtain cocrystal structures of PPARδ/γ-LBD and the three fibrates via X-ray diffraction and versatile crystallization methods, which we recently used to obtain 34 structures of PPARα-LBD cocrystallized with 17 ligands, including the fibrates. We herein reveal five novel high-resolution structures of PPARδ/γ–bezafibrate, PPARγ–fenofibric acid, and PPARδ/γ–pemafibrate, thereby providing the molecular basis for their application beyond dyslipidemia treatment.

Compositions containing gluten and polysaccharides that contain uronic acid residues useful for encapsulating fats, oils and solids

The present invention relates to compositions useful for encapsulating fats, oils or solids, comprising gluten and polysaccharides that contains uronic acid residues.

Herbicidal esters of D-1-(phenoxy-4-phenoxy)propionic acid

Optically active enantiomers of the formula I STR1 where R is a group of the formulae STR2 R1 and R2, among others, are halogen or CF3 and Z is a carboxyl, carboxylate, carboxylic acid ester, thioester, carbonamide, carboxylic acid anilide, carbohydrazide or thioamide group, are interesting herbicides the effect of which is considerably superior to that of the optically inactive racemates.